Susquehanna Fundamental Investments’s Avanos Medical AVNS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,917	Closed	-$509K	–	380
2023 Q2	$509K	Sell	19,917 -10,639	-35%	-$280K	0.02%	441
2023 Q1	$909K	Hold	30,556	–	–	0.02%	540
2022 Q4	$827K	Sell	30,556 -10,393	-25%	-$254K	0.01%	711
2022 Q3	$892K	Buy	+40,949	New	+$1.07M	0.02%	839
2022 Q1	$2.12M	Hold	63,315	–	–	0.04%	560
2021 Q4	$2.19M	Sell	63,315 -7,258	-10%	-$235K	0.06%	400
2021 Q3	$2.2M	Buy	70,573 +27,877	+65%	+$946K	0.04%	565
2021 Q2	$1.55M	Buy	+42,696	New	+$1.77M	0.03%	687

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's AVNS Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 19,917 shares — an estimated $509K sold.

Susquehanna Fundamental Investments first reported a position in AVNS in Q2 2021 and held it in 8 quarters. The position peaked at $2.2M in Q3 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

Susquehanna Fundamental Investments reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 19,917 Avanos Medical shares in Q3 2023, an estimated $509K.
Susquehanna Fundamental Investments first reported a position in Avanos Medical in Q2 2021 and held it in 8 quarters.
Susquehanna Fundamental Investments's Avanos Medical position peaked at $2.2M in Q3 2021.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.